See more : Unifoil Holdings, Inc. (UNFL) Income Statement Analysis – Financial Results
Complete financial analysis of Allied Healthcare Products, Inc. (AHPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allied Healthcare Products, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Hi-Target Navigation Tech Co.,Ltd (300177.SZ) Income Statement Analysis – Financial Results
- Auckland International Airport Limited (AIA.AX) Income Statement Analysis – Financial Results
- Farnova Group Holdings Limited (8153.HK) Income Statement Analysis – Financial Results
- Boardwalk Real Estate Investment Trust (BEI-UN.TO) Income Statement Analysis – Financial Results
- Kimbell Tiger Acquisition Corporation (TGR) Income Statement Analysis – Financial Results
Allied Healthcare Products, Inc. (AHPI)
About Allied Healthcare Products, Inc.
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in St. Louis, Missouri.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.05M | 36.28M | 31.89M | 31.38M | 33.76M | 33.51M | 35.95M | 35.46M | 36.37M | 38.55M | 43.45M | 46.78M | 46.03M | 52.07M | 56.36M | 56.50M | 57.55M | 56.12M | 59.10M | 60.86M | 60.41M | 64.93M | 64.28M | 72.80M | 96.50M | 118.10M | 120.10M | 111.60M | 74.10M | 61.20M | 58.60M | 54.60M |
| Cost of Revenue | 24.52M | 29.17M | 26.32M | 26.34M | 27.31M | 26.96M | 28.59M | 28.39M | 29.06M | 30.31M | 33.48M | 35.78M | 34.94M | 40.27M | 43.01M | 42.03M | 43.29M | 41.67M | 42.75M | 46.81M | 50.00M | 48.27M | 48.05M | 55.90M | 69.10M | 82.40M | 80.50M | 65.50M | 42.60M | 35.10M | 34.40M | 32.30M |
| Gross Profit | 2.53M | 7.11M | 5.57M | 5.04M | 6.45M | 6.56M | 7.36M | 7.07M | 7.31M | 8.24M | 9.96M | 11.00M | 11.09M | 11.80M | 13.36M | 14.47M | 14.25M | 14.45M | 16.35M | 14.05M | 10.42M | 16.66M | 16.22M | 16.90M | 27.40M | 35.70M | 39.60M | 46.10M | 31.50M | 26.10M | 24.20M | 22.30M |
| Gross Profit Ratio | 9.34% | 19.60% | 17.47% | 16.06% | 19.11% | 19.56% | 20.47% | 19.94% | 20.11% | 21.38% | 22.93% | 23.52% | 24.09% | 22.66% | 23.70% | 25.62% | 24.77% | 25.75% | 27.67% | 23.09% | 17.24% | 25.66% | 25.24% | 23.21% | 28.39% | 30.23% | 32.97% | 41.31% | 42.51% | 42.65% | 41.30% | 40.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 8.45M | 8.61M | 9.28M | 8.76M | 10.42M | 10.74M | 10.61M | 10.59M | 11.87M | 13.04M | 12.08M | 12.05M | 12.11M | 11.84M | 12.66M | 13.55M | 22.35M | 14.57M | 16.83M | 18.70M | 23.90M | 33.90M | 31.40M | 24.80M | 16.80M | 13.90M | 13.40M | 12.40M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.11M | 7.64M | 8.63M | 7.81M | 8.45M | 8.61M | 9.28M | 8.76M | 10.42M | 10.74M | 10.61M | 10.59M | 11.87M | 13.04M | 12.08M | 12.05M | 12.11M | 11.84M | 12.66M | 13.55M | 22.35M | 14.57M | 16.83M | 18.70M | 23.90M | 33.90M | 31.40M | 24.80M | 16.80M | 13.90M | 13.40M | 12.40M |
| Other Expenses | 0.00 | 0.00 | -18.25K | -130.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -17.60K | 2.20M | -3.00M | 100.00K | 100.00K | 2.90M | 1.60M | 1.10M | 1.10M | 1.20M |
| Operating Expenses | 7.11M | 7.64M | 8.63M | 7.81M | 8.45M | 8.61M | 9.28M | 8.76M | 10.42M | 10.74M | 10.61M | 10.59M | 11.87M | 13.04M | 12.08M | 12.05M | 12.11M | 11.84M | 12.66M | 13.55M | 22.35M | 14.57M | 16.82M | 20.90M | 20.90M | 34.00M | 31.50M | 27.70M | 18.40M | 15.00M | 14.50M | 13.60M |
| Cost & Expenses | 31.63M | 36.81M | 34.96M | 34.16M | 35.76M | 35.56M | 37.87M | 37.16M | 39.48M | 41.05M | 44.10M | 46.37M | 46.82M | 53.31M | 55.09M | 54.08M | 55.41M | 53.51M | 55.41M | 60.36M | 72.35M | 62.84M | 64.87M | 76.80M | 90.00M | 116.40M | 112.00M | 93.20M | 61.00M | 50.10M | 48.90M | 45.90M |
| Interest Income | 176.00 | 233.00 | 654.00 | 138.00 | 288.00 | 1.45K | 2.78K | 3.04K | 4.82K | 12.01K | 27.37K | 32.73K | 10.17K | 60.28K | -138.27M | -110.79M | -52.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 191.45K | 115.98K | 64.68K | 56.22K | 23.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 336.00 | 66.00 | 4.27K | 0.00 | 20.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 460.93K | 579.47K | 602.20K | 822.08K | 931.41K | 1.09M | 1.23M | 1.31M | 1.28M | 1.31M | 1.28M | 1.36M | 1.36M | 1.29M | 1.23M | 1.23M | 1.06M | 1.15M | 1.31M | 1.17M | 1.39M | 2.95M | 3.33M | 3.80M | 4.90M | 5.50M | 4.00M | 2.90M | 1.60M | 1.10M | 1.10M | 1.20M |
| EBITDA | -4.12M | 52.88K | -2.46M | -1.95M | -1.06M | -962.04K | -774.92K | -449.60K | -1.86M | -690.77K | 613.34K | 1.73M | 475.68K | -15.92M | 2.56M | 3.79M | 3.22M | 3.60M | 4.44M | 799.39K | -11.64M | 3.36M | 923.91K | -2.20M | 6.50M | -400.00K | 7.30M | 17.60M | 13.40M | 11.80M | 9.80M | 8.00M |
| EBITDA Ratio | -15.23% | 0.15% | -7.71% | -6.22% | -3.15% | -2.87% | -2.16% | -1.27% | -5.13% | -1.79% | 1.41% | 3.69% | 1.03% | -30.57% | 4.54% | 6.70% | 5.59% | 6.41% | 7.52% | 1.31% | -19.26% | 5.18% | 1.44% | -3.02% | 6.74% | -0.34% | 6.08% | 15.77% | 18.08% | 19.28% | 16.72% | 14.65% |
| Operating Income | -4.58M | -526.59K | -3.06M | -2.77M | -2.00M | -2.05M | -1.92M | -1.69M | -3.11M | -2.49M | -649.75K | 408.91K | -782.22K | -17.22M | 1.27M | 2.42M | 2.14M | 2.61M | 3.69M | 503.04K | -11.93M | 2.09M | -594.53K | -4.00M | 6.50M | 1.80M | 8.10M | 18.40M | 13.10M | 11.10M | 9.70M | 8.70M |
| Operating Income Ratio | -16.93% | -1.45% | -9.60% | -8.84% | -5.91% | -6.12% | -5.34% | -4.78% | -8.55% | -6.47% | -1.50% | 0.87% | -1.70% | -33.07% | 2.26% | 4.29% | 3.72% | 4.65% | 6.25% | 0.83% | -19.75% | 3.22% | -0.92% | -5.49% | 6.74% | 1.52% | 6.74% | 16.49% | 17.68% | 18.14% | 16.55% | 15.93% |
| Total Other Income/Expenses | -181.78K | 2.29M | -82.28K | 693.79K | -23.52K | -272.00 | -84.07K | -66.98K | -36.84K | 496.71K | -20.60K | -45.48K | -111.29K | 10.22K | 58.11K | 134.63K | 15.23K | -165.68K | -558.54K | -871.97K | -1.10M | -1.68M | -1.81M | -2.00M | -4.30M | -7.70M | -4.80M | -3.70M | -1.30M | -400.00K | -1.00M | -1.90M |
| Income Before Tax | -4.76M | 1.76M | -3.14M | -2.08M | -2.02M | -2.05M | -2.00M | -1.76M | -3.15M | -2.00M | -670.35K | 363.43K | -893.51K | -17.21M | 1.33M | 2.56M | 2.16M | 2.44M | 3.14M | -368.93K | -13.03M | 406.03K | -2.41M | -6.00M | 2.20M | -5.90M | 3.30M | 14.70M | 11.80M | 10.70M | 8.70M | 6.80M |
| Income Before Tax Ratio | -17.61% | 4.85% | -9.86% | -6.63% | -5.98% | -6.12% | -5.57% | -4.97% | -8.65% | -5.18% | -1.54% | 0.78% | -1.94% | -33.05% | 2.36% | 4.52% | 3.75% | 4.35% | 5.31% | -0.61% | -21.56% | 0.63% | -3.75% | -8.24% | 2.28% | -5.00% | 2.75% | 13.17% | 15.92% | 17.48% | 14.85% | 12.45% |
| Income Tax Expense | 599.67K | 72.48K | -130.36K | 29.45K | 173.04K | 36.50K | 301.43K | 16.60K | -339.81K | -740.04K | -245.92K | 159.02K | -293.94K | -449.78K | 448.75K | 914.40K | 506.85K | 100.78K | 1.26M | -211.37K | -1.29M | 171.89K | -694.96K | -1.90M | 9.00M | -1.40M | 1.50M | 5.90M | 4.50M | 4.00M | 3.10M | 2.50M |
| Net Income | -5.36M | 1.69M | -3.01M | -2.11M | -2.19M | -2.09M | -2.30M | -1.78M | -2.81M | -1.26M | -424.43K | 204.41K | -599.57K | -16.76M | 882.50K | 1.64M | 1.65M | 2.34M | 1.87M | -157.56K | -11.73M | 234.14K | -1.71M | -4.10M | -7.40M | -4.50M | 1.80M | 8.80M | 7.30M | 6.70M | 5.60M | 4.30M |
| Net Income Ratio | -19.82% | 4.65% | -9.45% | -6.72% | -6.49% | -6.23% | -6.41% | -5.01% | -7.71% | -3.26% | -0.98% | 0.44% | -1.30% | -32.19% | 1.57% | 2.91% | 2.86% | 4.17% | 3.17% | -0.26% | -19.42% | 0.36% | -2.67% | -5.63% | -7.67% | -3.81% | 1.50% | 7.89% | 9.85% | 10.95% | 9.56% | 7.88% |
| EPS | -1.34 | 0.42 | -0.75 | -0.53 | -0.55 | -0.52 | -0.57 | -0.44 | -0.70 | -0.31 | -0.10 | 0.05 | -0.15 | -4.24 | 0.22 | 0.42 | 0.42 | 0.60 | 0.48 | -0.04 | -3.00 | 0.06 | -0.44 | -1.05 | -1.90 | -1.15 | 0.50 | 2.90 | 2.62 | 1.88 | 1.56 | 1.32 |
| EPS Diluted | -1.34 | 0.42 | -0.75 | -0.53 | -0.55 | -0.52 | -0.57 | -0.44 | -0.70 | -0.31 | -0.10 | 0.05 | -0.15 | -4.24 | 0.22 | 0.41 | 0.41 | 0.58 | 0.47 | -0.04 | -3.00 | 0.06 | -0.44 | -1.05 | -1.90 | -1.15 | 0.49 | 2.90 | 2.62 | 1.88 | 1.56 | 1.32 |
| Weighted Avg Shares Out | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.04M | 4.06M | 4.05M | 4.03M | 3.95M | 3.94M | 3.94M | 3.92M | 3.91M | 3.91M | 3.91M | 3.90M | 3.90M | 3.89M | 3.90M | 3.90M | 3.90M | 3.60M | 3.03M | 2.79M | 3.56M | 3.59M | 3.26M |
| Weighted Avg Shares Out (Dil) | 4.01M | 4.03M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.01M | 4.04M | 4.06M | 4.06M | 4.03M | 3.95M | 4.06M | 4.04M | 4.03M | 4.04M | 3.99M | 3.91M | 3.90M | 4.06M | 3.90M | 3.90M | 3.90M | 3.90M | 3.64M | 3.03M | 2.79M | 3.56M | 3.59M | 3.26M |
FY2020 EPS Estimates for Steris PLC Lowered by KeyCorp (NYSE:STE)
Steris PLC (NYSE:STE) – Equities researchers at KeyCorp decreased their FY2020 earnings estimates for shares of Steris in a research report issued to clients and investors on Tuesday, April 28th. KeyCorp analyst M. Mishan now anticipates that the medical equipment...
Steris PLC (NYSE:STE) Shares Acquired by Copeland Capital Management LLC
Copeland Capital Management LLC lifted its position in shares of Steris PLC (NYSE:STE) by 11.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 78,210 shares of the medical equipment...
Steris PLC (NYSE:STE) Given Average Rating of "Buy" by Analysts
Steris PLC (NYSE:STE) has been assigned a consensus recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a...
Steris PLC (NYSE:STE) Expected to Post Quarterly Sales of $800.53 Million
Wall Street brokerages forecast that Steris PLC (NYSE:STE) will post sales of $800.53 million for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Steris’ earnings, with the highest sales estimate coming in at $808.00...
Steris (STE) to Release Quarterly Earnings on Monday
Steris (NYSE:STE) is set to issue its quarterly earnings data after the market closes on Monday, May 4th. Analysts expect the company to announce earnings of $1.63 per share for the quarter. Steris has set its FY 2020 After-Hours guidance...
Steris PLC (NYSE:STE) Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. reduced its position in Steris PLC (NYSE:STE) by 1.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 392,023 shares of the medical equipment provider’s stock after selling 5,985 shares during the quarter. Envestnet Asset Management...
CENTRAL TRUST Co Sells 157 Shares of Steris PLC (NYSE:STE)
CENTRAL TRUST Co lowered its holdings in shares of Steris PLC (NYSE:STE) by 30.8% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 353 shares of the medical equipment provider’s stock after selling...
Boston Trust Walden Corp Acquires 5,015 Shares of Steris PLC (NYSE:STE)
Boston Trust Walden Corp lifted its holdings in Steris PLC (NYSE:STE) by 3.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 166,676 shares of the...
Lenox Wealth Management Inc. Acquires 159 Shares of Steris PLC (NYSE:STE)
Lenox Wealth Management Inc. raised its holdings in shares of Steris PLC (NYSE:STE) by 16.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 1,129 shares of the medical equipment provider’s stock...
Dorsey Wright & Associates Makes New $1.35 Million Investment in Steris PLC (NYSE:STE)
Dorsey Wright & Associates acquired a new position in shares of Steris PLC (NYSE:STE) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 9,649 shares of the medical equipment...
Source: https://incomestatements.info
Category: Stock Reports